Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response.
Braitsch K, Jeske SD, Stroh J, Hefter M, Platen L, Bachmann Q, Renders L, Protzer U, Götze KS, Herhaus P, Verbeek M, Spinner CD, Bassermann F, Högner M, Haller B, Schneider J, Heider M.
Braitsch K, et al. Among authors: heider m.
Vaccines (Basel). 2024 Aug 1;12(8):871. doi: 10.3390/vaccines12080871.
Vaccines (Basel). 2024.
PMID: 39203997
Free PMC article.